Balyasny Asset Management
HIMS icon

Balyasny Asset Management’s Hims & Hers Health HIMS Stock Holding History

Balyasny Asset Management’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-53,796
Closed -$2.43M – 3039
2025
Q1 		$1.59M Buy
53,796
+19,653
+58% +$730K ﹤0.01% 1812
2024
Q4 		$826K Sell
34,143
-1,666,001
-98% -$41.3M ﹤0.01% 2009
2024
Q3 		$31.3M Buy
+1,700,144
New +$30.4M 0.05% 472
2024
Q1 		– Sell
-361,599
Closed -$3.22M – 2814
2023
Q4 		$3.22M Buy
+361,599
New +$2.67M 0.01% 1292
2023
Q2 		– Sell
-586,401
Closed -$5.82M – 2490
2023
Q1 		$5.82M Buy
+586,401
New +$5.14M 0.01% 1016
2022
Q2 		– Sell
-103,837
Closed -$553K – 2917
2022
Q1 		$553K Buy
103,837
+91,474
+740% +$452K ﹤0.01% 1793
2021
Q4 		$81K Buy
+12,363
New +$89.4K ﹤0.01% 1995
2021
Q2 		– Sell
-10,364
Closed -$137K – 2118
2021
Q1 		$137K Buy
+10,364
New +$174K ﹤0.01% 1608

Other funds holding HIMS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DE
Defiance ETFs New York $6.98B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Balyasny Asset Management's HIMS Position: Q2 2025 in Review

Balyasny Asset Management sold out of Hims & Hers Health (HIMS) in Q2 2025, closing a stake of 53,796 shares — an estimated $2.43M sold.

Balyasny Asset Management first reported a position in HIMS in Q1 2021 and held it in 8 quarters. The position peaked at $31.3M in Q3 2024. 510 funds tracked by Wall St. Rank hold HIMS as of Q2 2025.

  • Balyasny Asset Management reported no remaining Hims & Hers Health position as of Q2 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 53,796 Hims & Hers Health shares in Q2 2025, an estimated $2.43M.
  • Balyasny Asset Management first reported a position in Hims & Hers Health in Q1 2021 and held it in 8 quarters.
  • Balyasny Asset Management's Hims & Hers Health position peaked at $31.3M in Q3 2024.
  • 510 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2025.

Based on Balyasny Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.